| anti-obesity agents | Agents that increase energy expenditure and weight loss by neural and chemical regulation. Beta-adrenergic agents and serotoninergic drugs have been experimentally used in patients with non-insulin dependent diabetes mellitus (niddm) to treat obesity. (12 Dec 1998) |
|---|---|
| anti-P antibody | <haematology, investigation> A serologic blood test used to detect the Donath-landsteiner antibody in serum. This test is performed in cases of suspected paroxysmal cold haemoglobinuria. A normal result is indicated by an absence of antibodies. The antibody is directed toward the P-antigen complex which is located on the surface of red blood cells. In some way, cold temperatures trigger the antibody to bind to this site. (13 Jan 1998) |
| anti-platelet agents | Medications that, like aspirin, reduce the tendency of platelets in the blood to clump and clot. (12 Dec 1998) |
| anti-S | See MNSs blood group, Blood Groups appendix. (05 Mar 2000) |
| anti-streptolysin O titres | <immunology, microbiology> A special serologic test, known as anti-streptolysin O, that measures the quantity of antibody to a component of streptococcal bacteria. A useful diagnostic test for scarlet fever, rheumatic fever and other streptococcal disease. (13 Jan 1998) |
| anti-tac | Monoclonal antibody that recognises a drain of the IL-2 receptor. (05 Mar 2000) |
| anti-ulcer agents | Various agents with different action mechanisms used to treat or ameliorate ulcers or irritation of the gastrointestinal tract. (12 Dec 1998) |
| British anti-Lewisite | <chemical> 2,3-dimercapto-1-propanol. An anti-gas warfare agent that is effective against lewisite (dichloro(2-chlorovinyl)arsine). It acts as a chelating agent and is used in the treatment of arsenic, gold, and other heavy metal poisoning. Pharmacological action: antidotes, chelating agents. Chemical name: 1-Propanol, 2,3-dimercapto- (12 Dec 1998) |
| medication, anti-coagulant | Blood thinners. Drugs, like heparin and warfarin, used as blood-thinners to prevent blood clots and to maintain open blood vessels. (12 Dec 1998) |
| medication, anti-platelet | Platelet-blocking drugs. Drugs that, like aspirin, reduce the tendency of platelets in the blood to clump and clot. (12 Dec 1998) |
| haemoglobin Anti-Lepore | A group of abnormal haemoglobins similar to haemoglobin Lepore. These haemoglobins have normal a chains, but the non-a chain consists of the N-terminal portion of the b chain joined to the C-terminal portion of the d chain. This is the opposite crossing over pattern observed in haemoglobin Lepore. Examples of haemoglobin Anti-Lepore include HbMiyada, Hb PCongo, Hb PNilotic, and HbLincoln Park. There is also one variant that is both haemoglobin Lepore and haemoglobin Anti-Lepore (HbParchman). Compare: haemoglobin Lepore. (05 Mar 2000) |
| non-steroidal anti-inflammatory | <pharmacology> A large group of anti-inflammatory agents that work by inhibiting the production of prostaglandins. They exert anti-inflammatory, analgesic and antipyretic actions. Examples include: ibuprofen, ketoprofen, piroxicam, naproxen, sulindac, aspirin, choline subsalicylate, diflunisal, fenoprofen, indomethacin, meclofenamate, salsalate, tolmetin and magnesium salicylate. A contrast is made with steroidal compounds (such as hydrocortisone or prednisone) exerting anti-inflammatory activity. Acronym: NSAID (05 May 2002) |
| non-steroidal anti-inflammatory drug | <pharmacology> A large group of anti-inflammatory agents that work by inhibiting the production of prostaglandins. They exert anti-inflammatory, analgesic and antipyretic actions. Examples include: ibuprofen, ketoprofen, piroxicam, naproxen, sulindac, aspirin, choline subsalicylate, diflunisal, fenoprofen, indomethacin, meclofenamate, salsalate, tolmetin and magnesium salicylate. A contrast is made with steroidal compounds (such as hydrocortisone or prednisone) exerting anti-inflammatory activity. Acronym: NSAID (05 May 2002) |
| drug, anti-infective | A medication capable of acting against infection, by inhibiting the spread of an infectious agent or by killing the infectious agent outright. (12 Dec 1998) |